News & Press Releases
Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device.
June 4th, 2013
INTEGRITY APPLICATIONS RECEIVES CE MARK APPROVAL FOR ITS GLUCOTRACK® MODEL DF-F GLUCOSE MONITORING DEVICE ASHKELON, Israel (June 4, 2013) – Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device. Receipt of the CE Mark allows Integrity Applications to market and sell […]
Read More DownloadINTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP”
April 10th, 2013
INTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP” Raises approximately $6.3 million to advance the development and commercialization of GlucoTrack® for the non-invasive measurement of blood glucose ASHKELON, Israel (April 9, 2013) – Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack DF-F non-invasive blood glucose […]
Read More DownloadIntegrity applications has been certified to ISO 13485:2003 standard.
March 14th, 2013
Read More DownloadFrost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation…
July 16th, 2008
Frost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation and Growth Potential in the Non-Invasive Glucose Monitoring Markets PALO ALTO, Calif.–(Business Wire)– Based on its recent analysis of the biosensors market, Frost & Sullivan recognizes Integrity Applications Ltd. with the 2008 North American Frost & Sullivan Product Innovation Leadership of the Year Award for developing the […]
Read More
